Meng Y - Search Results

1

Ubiquitin-specific protease 22 controls melanoma metastasis and vulnerability to ferroptosis through targeting SIRT1/PTEN/PI3K signaling.

Sun H, Meng Y, Yao L, Du S, Li Y, Zhou Q, Liu Y, Dian Y, Sun Y, Wang X, Liang XW, Deng G, Chen X, Zeng F. Sun H, et al. Among authors: meng y. MedComm (2020). 2024 Aug 12;5(8):e684. doi: 10.1002/mco2.684. eCollection 2024 Aug. MedComm (2020). 2024. PMID: 39135915 Free PMC article.

2

The Prognostic Significance of Baseline Neutrophil-to-Lymphocyte Ratio in Melanoma Patients Receiving Immunotherapy.

Li Y, Meng Y, Sun H, Ye L, Zeng F, Chen X, Deng G. Li Y, et al. Among authors: meng y. J Immunother. 2022 Jan 1;45(1):43-50. doi: 10.1097/CJI.0000000000000392. J Immunother. 2022. PMID: 34510106 Free PMC article. Review.

3

EEF2K silencing inhibits tumour progression through repressing SPP1 and synergises with BET inhibitors in melanoma.

Deng G, Zeng F, He Y, Meng Y, Sun H, Su J, Zhao S, Cheng Y, Chen X, Yin M. Deng G, et al. Among authors: meng y. Clin Transl Med. 2022 Feb;12(2):e722. doi: 10.1002/ctm2.722. Clin Transl Med. 2022. PMID: 35184394 Free PMC article.

4

Melanoma survivors are at increased risk for second primary keratinocyte carcinoma.

Sun H, Li Y, Zeng F, Meng Y, Du S, Deng G. Sun H, et al. Among authors: meng y. Int J Dermatol. 2022 Nov;61(11):1397-1404. doi: 10.1111/ijd.16309. Epub 2022 Jun 21. Int J Dermatol. 2022. PMID: 35726477

5

Targeting Ferroptosis by Ubiquitin System Enzymes: A Potential Therapeutic Strategy in Cancer.

Meng Y, Sun H, Li Y, Zhao S, Su J, Zeng F, Deng G, Chen X. Meng Y, et al. Int J Biol Sci. 2022 Aug 29;18(14):5475-5488. doi: 10.7150/ijbs.73790. eCollection 2022. Int J Biol Sci. 2022. PMID: 36147464 Free PMC article. Review.

6

BET inhibitors synergize with sunitinib in melanoma through GDF15 suppression.

Zeng F, Li Y, Meng Y, Sun H, He Y, Yin M, Chen X, Deng G. Zeng F, et al. Among authors: meng y. Exp Mol Med. 2023 Feb;55(2):364-376. doi: 10.1038/s12276-023-00936-y. Epub 2023 Feb 1. Exp Mol Med. 2023. PMID: 36720918 Free PMC article.

7

Risk and outcomes of breakthrough COVID-19 infections in vaccinated immunocompromised patients: A meta-analysis.

Deng G, Zhou Q, Meng Y, Sun H, Du S, Liu Y, Zeng F. Deng G, et al. Among authors: meng y. MedComm (2020). 2023 Jun 9;4(3):e307. doi: 10.1002/mco2.307. eCollection 2023 Jun. MedComm (2020). 2023. PMID: 37303815 Free PMC article. No abstract available.

8

Molecular landmarks of tumor disulfidptosis across cancer types to promote disulfidptosis-target therapy.

Zhao D, Meng Y, Dian Y, Zhou Q, Sun Y, Le J, Zeng F, Chen X, He Y, Deng G. Zhao D, et al. Among authors: meng y. Redox Biol. 2023 Dec;68:102966. doi: 10.1016/j.redox.2023.102966. Epub 2023 Nov 19. Redox Biol. 2023. PMID: 38035663 Free PMC article.

9

BET inhibitors potentiate melanoma ferroptosis and immunotherapy through AKR1C2 inhibition.

Meng Y, Sun HY, He Y, Zhou Q, Liu YH, Su H, Yin MZ, Zeng FR, Chen X, Deng GT. Meng Y, et al. Mil Med Res. 2023 Dec 4;10(1):61. doi: 10.1186/s40779-023-00497-1. Mil Med Res. 2023. PMID: 38049916 Free PMC article. No abstract available.

10

Ferroptosis in cancer: From molecular mechanisms to therapeutic strategies.

Zhou Q, Meng Y, Li D, Yao L, Le J, Liu Y, Sun Y, Zeng F, Chen X, Deng G. Zhou Q, et al. Among authors: meng y. Signal Transduct Target Ther. 2024 Mar 8;9(1):55. doi: 10.1038/s41392-024-01769-5. Signal Transduct Target Ther. 2024. PMID: 38453898 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

8,100 results

Search Page

Filters